Enter assignee name

Forward Citations = 17

Loading Chart...

12 inventors (with patents filed for the assignee):

Yuefeng Lu (10 out of 11 patents)

Jian-Feng Lu (9 out of 11 patents)

Kurt Shanebeck (4 out of 4 patents)

4. Lu Li (3 out of 3 patents)

5. Lan Yang (3 out of 3 patents)

6. Aijun Wang (2 out of 2 patents)

7. Donggou He (2 out of 2 patents)

8. Chen Yao (2 out of 2 patents)

9. Shiwen Zhang (2 out of 2 patents)

10. Lei Liu (2 out of 2 patents)

11. Chunxiao Yu (2 out of 2 patents)

12. Fang Xia (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12459980 - IL-21 prodrugs and methods of use thereof (2025-11-04),

2. 12312413 - Antibodies and methods for making and using the same (2025-05-27),

3. 12043662 - Angiopoietin 2, VEGF dual antagonists (2024-07-23),

4. 11845801 - IL-15 prodrugs and methods of use thereof (2023-12-19),

5. 11746147 - Angiopoietin 2, VEGF dual antagonists (2023-09-05),

6. 11505618 - Antibodies and methods for making and using the same (2022-11-22),

7. 11059885 - Angiopoietin 2, VEGF dual antagonists (2021-07-13),

8. 10654922 - Angiopoietin 2, VEGF dual antagonists (2020-05-19),

9. 10287336 - Feline erythropoietin receptor agonists (2019-05-14),

10. 10077308 - PD-L1 specific monoclonal antibodies for disease treatment and diagnosis (2018-09-18),

Askgene Pharma Inc. is a leading biotechnology company focused on developing innovative therapies for genetic diseases. With a dedicated team of scientists, we are committed to advancing precision medicine through cutting-edge research and technology. Our mission is to improve patient outcomes and quality of life by harnessing the power of genetics. Visit our website to learn more about our pipeline of products and ongoing clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

10 Patents

#30 in Camarillo, CA

#6,885 in California

#28,957 in US

#54,287 in the World

Camarillo, CA, United States of America

Askgene Pharma Inc.